Table of Contents Author Guidelines Submit a Manuscript
Advances in Preventive Medicine
Volume 2012 (2012), Article ID 874615, 5 pages
Research Article

Development of Combination HIV Prevention Programs for People Who Inject Drugs through Government and Civil Society Collaboration in the Russian Federation

1Center for Social Development and Information (Population Services International/Russia), 125315 Moscow, Russia
2Institute for Public Health and Health Management, First Moscow State Medical University, 119021 Moscow, Russia
3Division of Pharmacologic Therapies, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, Rockville, MD 20857, USA
4Division for Anti-Drug Work Coordination, Cabinet of Ministers of the Republic of Tatarstan, Kazan, 420060 Republic of Tatarstan, Russia
5Public Organization “Prevention and Initiative”, Kazan, 420044 Republic of Tatarstan, Russia
6Republican Drug Treatment Hospital, Kazan, 420082 Republic of Tatarstan, Russia

Received 9 August 2012; Revised 18 October 2012; Accepted 1 November 2012

Academic Editor: Kevin P. Mulvey

Copyright © 2012 M. V. Volik et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Population Services International (PSI) has worked collaboratively with several government institutions of the Russian Federation to develop and implement a model program to access health services for individuals who are opioid dependent, including those with HIV infection. Through the development of partnership agreements between government organizations (GOs) and non-government organizations (NGOs), a model of the continuum of care has been developed that identifies a Recommended Package of HIV Prevention Services for Injecting Drug Users (RPS-IDU). The implementation of the RPS-IDU in the Russian Federation offers a model for other countries with HIV epidemics associated with injection drug use. This paper will describe the model program and its implementation in one of the pilot program regions.